Two Sigma Securities, LLC Akari Therapeutics PLC Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.16 - $0.22 $2,818 - $3,874	17,613 New	17,613 $2,000
Q4 2022 Feb 14, 2023	BUY	$0.41 - $12.8 $5,505 - $171,891	13,429 New	13,429 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.95 - $1.22 $31,114 - $39,957	32,752 New	32,752 $33,000
Q1 2020 May 15, 2020	SELL	$1.06 - $2.16 $13,386 - $27,278	-12,629 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.69 - $2.16 $21,343 - $27,278	12,629 New	12,629 $22,000
Q2 2019 Aug 14, 2019	SELL	$1.89 - $4.01 $39,330 - $83,448	-20,810 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.66 - $5.9 $34,544 - $122,779	20,810 New	20,810 $74,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $59.3M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.